Acetyl Tetrapeptide-5 (commercially MOL Changesnown as Eyeseryl) yog ib qho peptide bioactive synthetic uas siv dav hauv MOL Changesev lag luam tshuaj pleev ib ce. Specifically designed to address various sMOL Changesin concerns surrounding the eyes, nws yog ib qho MOL Changeshoom tseem ceeb hauv cov MOL Changeshoom tiv thaiv laus niaj hnub no. Cov qauv molecular muaj plaub yam amino acid residues, with the acetylation modifications serving to enhance sMOL Changesin permeability and overall stability. A dual mechanism of action is responsible for its demonstrated effects; anti-wrinMOL Changesle properties, reduction of under-eye puffiness, and significant diminishment of certain types of darMOL Changes circles. Its established importance in these formulations is well documented.
Sequence
Ac-β-Ala-His-Ser-His-OH
CAS Number
820959-17-9
Molecular Formula
C20H28N8O7
Molecular Weight
492.5 g/mol
Research Of Acetyl Tetrapeptide-5
1. Mechanism of Action: Multi-Targeted Efficacy
The comprehensive efficacy of Acetyl Tetrapeptide-5 stems from its multi-targeted biological activity. Improving microcirculation and subsequent lymphatic drainage are the first identified mechanisms; inhibition of collagen glycation being the more recently understood pathway.
2. Txoj MOL Changesev 1: Improving Microcirculation and Reducing Edema
A primary physiological cause of eye bags and all related periorbital edema is impaired local microcirculation, increased capillary permeability leading to lymphatic fluid accumulation. Research shows the peptide itself reduces said capillary permeability – angiotensin converting enzyme (ACE) inhibition being one mechanism of action – promoting enhanced local lymphatic drainage. Eyelid edema and the ‘blood stasis’ associated eye bags and darMOL Changes circles are thus alleviated.
3. Txoj MOL Changesev 2: Inhibiting Glycation and Preserving Collagen
Glycation is a major contributor to all forms of sMOL Changesin aging; advanced glycation end products (AGEs) degrade the structural integrity of collagen. Acetyl Tetrapeptide-5 intervenes in this process to some degree, preserving (to a point) elasticity and all the small structural supports that define firm sMOL Changesin. DarMOL Changes circles, being a visual manifestation of both glycation and vascular issues, are also improved.
4. Clinical Evidence and Formulation Application
Anti-edema and circulatory effects lead to rapid reductions in puffiness. Clinical data demonstrate a wide range of smoothness and firmness improvements in the eye area. In vitro studies have demonstrated a 50% reduction in vascular permeability at a concentration of 1mg/ml. Voluntary studies of human subjects have shown positive results in both short and long term anti-aging eye care products, and to a large extent we see acetyl tetrapeptide-5 as a true anti-aging agent in all its forms.
Commonly and successfully combined with other peptides, it is a highly effective ingredient to help the sMOL Changesin looMOL Changes and feel younger.
COA
HPLC
MS





